Endlyz Therapeutics
Company

Endlyz Therapeutics

Biotechnology Research Time Split Between London and Oxford. 7 employees
Employees
7
Contacts
4
Emails
4

Endlyz Therapeutics Overview

Headquarters
Time Split Between London and Oxford.
Website
www.endlyz.com
Industry
Biotechnology Research
Employees
7
Founded
2021
Funding
2.2M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Endlyz Therapeutics

Endlyz Therapeutics Inc. and Endlyz UK Ltd (together ‘Endlyz’) are developing disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias. By leveraging extensive industry experience, a robust investor syndicate, and academic collaborations that provide access to advanced technologies on an exclusive basis, Endlyz is well positioned to lead the industry in our programmes. The company is open to discuss collaborations and in-licensing of complimentary programmes.

Endlyz Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage

Endlyz Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Tim Edwards
Email
Floriana Licitra Associate Director, R&D
Email
Ross Hutchinson Head of Operations at Endlyz
Email
Craig Fox Operating Partner (Lifesciences)
Email

Employees by Management Level

VP / Head 1 profile
Director 1 profile
Individual contributor 1 profile

Compare Similar Companies to Endlyz Therapeutics